rs143309484
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_013280.5(FLRT1):c.1712G>T(p.Gly571Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,613,662 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013280.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLRT1 | NM_013280.5 | c.1712G>T | p.Gly571Val | missense_variant | 3/3 | ENST00000682287.1 | NP_037412.2 | |
MACROD1 | NM_014067.4 | c.517+33260C>A | intron_variant | ENST00000255681.7 | NP_054786.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLRT1 | ENST00000682287.1 | c.1712G>T | p.Gly571Val | missense_variant | 3/3 | NM_013280.5 | ENSP00000507207.1 | |||
MACROD1 | ENST00000255681.7 | c.517+33260C>A | intron_variant | 1 | NM_014067.4 | ENSP00000255681.6 |
Frequencies
GnomAD3 genomes AF: 0.000808 AC: 123AN: 152212Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000643 AC: 161AN: 250212Hom.: 0 AF XY: 0.000583 AC XY: 79AN XY: 135484
GnomAD4 exome AF: 0.00138 AC: 2020AN: 1461450Hom.: 3 Cov.: 90 AF XY: 0.00134 AC XY: 975AN XY: 727056
GnomAD4 genome AF: 0.000808 AC: 123AN: 152212Hom.: 0 Cov.: 34 AF XY: 0.000659 AC XY: 49AN XY: 74352
ClinVar
Submissions by phenotype
Peripheral neuropathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C15"). ClinVar contains an entry for this variant (Variation ID: 530936). This variant has not been reported in the literature in individuals affected with FLRT1-related conditions. This variant is present in population databases (rs143309484, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 571 of the FLRT1 protein (p.Gly571Val). - |
FLRT1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at